AstraZeneca PLCAZN

$174.93-2.96 (-1.66%)

NYSEHealthcare24:00 UTC

Company snapshot

Market Cap

$273B

Mega-cap

+289%

2016 — today

10-Year Price

+216%

2016 — today

52-Week Range

$137.58$209.48

Current $174.93· 52%

AstraZeneca discovers, develops, manufactures, and commercializes prescription medicines globally. Its portfolio addresses cardiovascular, renal, metabolic, and oncological conditions, alongside rare diseases and COVID-19 solutions like Tagrisso, Farxiga, Symbicort, and Soliris. Operating worldwide, the firm drives innovation through strategic collaborations with partners like Neurimmune, BenevolentAI, Lunit, and Absci. Formed in 1992 as Zeneca Group, it rebranded in 1999 and is based in Cambridge, UK.